Capsulomics offers novel diagnostic tests that detect esophagus cancer in early stages, resolving diagnostic and prognostic uncertainty. The company's mission is to detect cancer of the esophagus and its pre-cancerous condition early, when it can be more effectively treated and often cured. Capsulomics' early-detection system is convenient, inexpensive, and accurate, providing a simple routine test that can be given to those at risk before cancer symptoms arise, empowering patients to know earlier, receive necessary treatments, and live a healthier, longer life.